High-risk patients: modern treatment strategy
This review summarizes modern views on high-risk patients as atherosclerosis-free individuals. The importance of high-risk approach is explained by the fact that this group encompasses the majority of cardiac patients, as well as the majority of cardiovascular events. Therefore, early diagnostics an...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2151 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849250724416847872 |
|---|---|
| author | D. V. Nebieridze A. Meliya |
| author_facet | D. V. Nebieridze A. Meliya |
| author_sort | D. V. Nebieridze |
| collection | DOAJ |
| description | This review summarizes modern views on high-risk patients as atherosclerosis-free individuals. The importance of high-risk approach is explained by the fact that this group encompasses the majority of cardiac patients, as well as the majority of cardiovascular events. Therefore, early diagnostics and adequate management of high-risk patients could substantially reduce the incidence of cardiovascular events. The modern treatment strategy for high-risk patients requires pharmaceutical intervention, and has the same principles as the treatment of patients with diagnosed cardiovascular disease. Such components of pharmaceutical treatment as antihypertensive, lipidlowering, and anti-aggregant therapy are discussed in detail. |
| format | Article |
| id | doaj-art-dd645c8eafcc4de898a5bb427aa9ae94 |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2010-12-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-dd645c8eafcc4de898a5bb427aa9ae942025-08-20T03:57:09Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252010-12-0196971011860High-risk patients: modern treatment strategyD. V. Nebieridze0A. Meliya1State Research Centre for Preventive Medicine. MoscowCardiology Clinic “Guli”. TbilisiThis review summarizes modern views on high-risk patients as atherosclerosis-free individuals. The importance of high-risk approach is explained by the fact that this group encompasses the majority of cardiac patients, as well as the majority of cardiovascular events. Therefore, early diagnostics and adequate management of high-risk patients could substantially reduce the incidence of cardiovascular events. The modern treatment strategy for high-risk patients requires pharmaceutical intervention, and has the same principles as the treatment of patients with diagnosed cardiovascular disease. Such components of pharmaceutical treatment as antihypertensive, lipidlowering, and anti-aggregant therapy are discussed in detail.https://cardiovascular.elpub.ru/jour/article/view/2151high-risk patientsantihypertensive therapylipid-lowering therapyanti-aggregant therapyaspirin® cardio |
| spellingShingle | D. V. Nebieridze A. Meliya High-risk patients: modern treatment strategy Кардиоваскулярная терапия и профилактика high-risk patients antihypertensive therapy lipid-lowering therapy anti-aggregant therapy aspirin® cardio |
| title | High-risk patients: modern treatment strategy |
| title_full | High-risk patients: modern treatment strategy |
| title_fullStr | High-risk patients: modern treatment strategy |
| title_full_unstemmed | High-risk patients: modern treatment strategy |
| title_short | High-risk patients: modern treatment strategy |
| title_sort | high risk patients modern treatment strategy |
| topic | high-risk patients antihypertensive therapy lipid-lowering therapy anti-aggregant therapy aspirin® cardio |
| url | https://cardiovascular.elpub.ru/jour/article/view/2151 |
| work_keys_str_mv | AT dvnebieridze highriskpatientsmoderntreatmentstrategy AT ameliya highriskpatientsmoderntreatmentstrategy |